An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells
ImmunoTargets and Therapy · 2026-05 · Volume 15 · 1-16
DOI: 10.2147/itt.s594441 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-05. Verfasst von Sze-Piaw Chin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Cytopeutics Sdn Bhd, Cyberjaya, Selangor, Malaysia. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Cytokine-induced killer (CIK) cells are a promising adoptive immunotherapy due to their non-major histocompatibility complex (MHC)-restricted cytotoxicity. However, their cytokine-mediated response against CRC remains poorly defined.
Methods
In this exploratory study, CIK cells were generated from three healthy donors and one metastatic CRC patient. Phenotypes were assessed by flow cytometry. Cytotoxicity against the HCT-15 CRC cell line was evaluated at multiple effector-to-target (E:T) ratios (1:5 to 40:1). Combination treatment with 5-fluorouracil (5-FU) and cytokine profiling using a 105-plex array were performed using CIK cells from donor 2 and donor 3, respectively.
Results
CIK cells derived from one CRC patient exhibited phenotypic characteristics (CD3⁺CD8⁺ 85.91%, CD3⁺CD56⁺ 27.81%) comparable to the range observed in three healthy donors. Co-culture with CIK cells from donor 1 resulted in reduced HCT-15 viability at higher E:T ratios, with viability decreasing to 8.98 ± 0.61% and 8.08 ± 2.00% at 20:1 and 40:1, respectively. In combination experiments, HCT-15 viability was reduced to 1.02 ± 1.01% at an E:T ratio of 20:1 when co-cultured with CIK from donor 2 and treated with 5-FU. Similar reductions were observed with CIK cells from donor 3 and the CRC patient, reaching 2.60 ± 5.86% and 0.0% at 20:1, and 0.0% at 40:1 ratio for both donors. CIK cells from all donors showed dose-dependent reduction in cell viability against HCT-15 cells. Cytokine profiling of CIK from donor 3 identified changes in immune-related factors, including upregulation of interferon gamma-inducible chemokines (CXCL9 and CXCL10), alongside downregulation of immunosuppressive mediators such as TIM-3 and VEGF.
Conclusion
This exploratory study demonstrates that functional CIK cells can be generated from healthy individuals and CRC patients, with observed cytotoxic activity against HCT-15 cells. The findings suggest potential immunomodulatory effects and support further investigation of CIK cells in combination strategies; however, larger patient cohorts and functional validation studies are required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Development, Cytopeutics Sdn Bhd, Cyberjaya, Selangor, Malaysia.
- M. Kandiah Faculty of Medicine & Health Sciences, University Tunku Abdul Rahman Sungai Long City Campus, Kajang, Selangor, Malaysia.
- Laboratory Department, CryoCord Sdn Bhd, Cyberjaya, Selangor, Malaysia.
ORCID-Profile: Sze-Piaw Chin, Soon-Keng Cheong
Zitieren
APA
Chin, S. P., Nor Arfuzir, N. N., Kong, V. W., & Cheong, S. K. (2026). An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells. ImmunoTargets and Therapy, Volume 15, 1-16. https://doi.org/10.2147/itt.s594441
Vancouver
Chin SP, Nor Arfuzir NN, Kong VW, Cheong SK. An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells. ImmunoTargets and Therapy. 2026;Volume 15:1-16. doi:10.2147/itt.s594441
BibTeX
@article{Chin2026,
author = {Chin, Sze-Piaw and Nor Arfuzir, Natasha Najwa and Kong, Vivian Wai-Ping and Cheong, Soon-Keng},
title = {An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells},
journal = {ImmunoTargets and Therapy},
year = {2026},
volume = {Volume 15},
pages = {1--16},
doi = {10.2147/itt.s594441}
}
EUVIMED